SCHEMBL3202139

SCHEMBL3202139

Cc1cccnc1N1CCN(S(=O)(=O)c2csc3ccccc23)CC1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 7/20 0.58
HTR6 P50406 2/20 0.48
ABCB1 P08183 1/20 0.47
ABCC1 P33527 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
F13A1 P00488 1/20 0.47
TGM2 P21980 1/20 0.47
TGM1 P22735 1/20 0.47
TGM3 Q08188 1/20 0.47
GBA1 P04062 3/20 0.46
ALDH1A1 P00352 2/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
COMT P21964 1/20 0.42
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3215996 0.84 HSD11B1 (0.69) HSD11B1
SCHEMBL3224518 0.79 HSD11B1 (0.65) HSD11B1F13A1TGM2TGM1TGM3
SCHEMBL3221605 0.78 HSD11B1 (0.64) HSD11B1F13A1TGM2TGM1TGM3
SCHEMBL3201987 0.78 HSD11B1 (0.64) HSD11B1F13A1TGM2TGM1TGM3
SCHEMBL3217908 0.76 HSD11B1 (0.58) HSD11B1ABCB1ABCC1ABCG2F13A1
SCHEMBL3224595 0.75 HSD11B1 (0.66) HSD11B1GBA1
SCHEMBL3223586 0.74 HSD11B1 (0.72) HSD11B1F13A1TGM2TGM1TGM3
SCHEMBL3223804 0.73 HSD11B1 (0.79) HSD11B1F13A1TGM2TGM1TGM3
SCHEMBL3225781 0.73 HSD11B1 (0.60) HSD11B1F13A1TGM2TGM1TGM3
SCHEMBL12626562 0.73 HTR6 (0.52) HTR6ALDH1A1SMN1; SMN2POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 HSD11B1 1/4885HTR6 2021/4885ABCB1 781/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885HTR6 1213/4885ABCB1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.